Filtered By:
Condition: Diabetes
Nutrition: Weight Loss
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 290 results found since Jan 2013.
Development of a Mobile Application Platform for Self-Management of Obesity Using Artificial Intelligence Techniques
Int J Telemed Appl. 2021 Aug 27;2021:6624057. doi: 10.1155/2021/6624057. eCollection 2021.ABSTRACTObesity is a major global health challenge and a risk factor for the leading causes of death, including heart disease, stroke, diabetes, and several types of cancer. Attempts to manage and regulate obesity have led to the implementation of various dietary regulatory initiatives to provide information on the calorie contents of meals. Although knowledge of the calorie content is useful for meal planning, it is not sufficient as other factors, including health status (diabetes, hypertension, etc.) and level of physical activity,...
Source: International Journal of Telemedicine and Applications - September 6, 2021 Category: Information Technology Authors: Sylvester M Sefa-Yeboah Kwabena Osei Annor Valencia J Koomson Firibu K Saalia Matilda Steiner-Asiedu Godfrey A Mills Source Type: research
Malnutrition Prevalence Rates among Dutch Nursing Home Residents: What Has Changed over One Decade? A Comparison of the Years 2009, 2013 and 2018
ConclusionEven though much attention has been paid to prevent malnutrition in Dutch nursing homes over the last decades, results show a relatively stable malnutrition prevalence rate of around 16%. This leads to the question if nursing staff is able to sufficiently recognize residents with (a risk of) malnutrition, and if they are aware of interventions they could perform to decrease this rate.
Source: The Journal of Nutrition, Health and Aging - September 4, 2021 Category: Nutrition Source Type: research
Prevention of Diabetes Macrovascular Complications and Heart Failure
Cardiovascular (CV) mortality in diabetes has declined substantially over the last 3 decades in high-income countries from a multifactorial approach targeting glucose, cholesterol, and blood pressure, and lower smoking rates. Additional CV gains may be achieved from large-scale weight loss, which ongoing trials are testing, and from delaying diabetes in those at highest risk. Fina lly, recent outcome trials support a role for (1) sodium/glucose cotransporter-2 inhibitors, which lower major adverse cardiovascular events but incident heart failure more strongly, and (2) glucagon-like peptide-1 receptor agonists, which lowe...
Source: Endocrinology and Metabolism Clinics of North America - July 12, 2021 Category: Endocrinology Authors: Naveed Sattar Source Type: research
